CClinicalTrials.gg
CompletedNCT03637985exerciseUpdated Aug 20, 2018

Effect of 12 Weeks of Resistive Exercises Versus Aerobic Exercises in Overweight Hypertensive Postmenopausal Women

An interventional study of resistive exercise and aerobic exercise in form of treadmill walking in Exercise, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 50 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-08-20.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Sep 2017, registered Aug 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years to 60 Years
Sex
Female
01

Study summary

Sixty postmenopausal women participated in this study from gynecological outpatient clinic, at Al-Zahra universal Hospital, Al Azhar University, and Cairo. They were first diagnosed to be hypertensive in their early postmenopausal period .Their blood pressure ranged between 140/90mmHg to 170/105mmHg, their ages ranged from 50 to 60 years and their body mass index ranged from 30:35 kg/m2.

Read the detailed description

The participants were divided randomly according to closed envelop into three equal groups in number: Group A (RE) consisted of twenty women who participated in the resistive exercise program. Group B (AE) group: consisted of twenty women who participated in an aerobic exercise program. All patients in both groups (A \& B) participated in the exercises three times per week for twelve weeks and every session lasted for 45 min and continues their antihypertensive medication

02

Conditions studied

  • Exercise

Keywords

  • resistive exercises
  • aerobic
  • Menopause
  • hypertension
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • All women diagnosed as essential hypertension.
  • All women must be in their early postmenopausal period

Exclusion criteria

Exclusion Criteria:

  • Lesion to higher centers leading to hypertension (embolism)
  • any cardiovascular disease
  • premature menopause
  • surgical menopause
  • severe hypertension
  • diabetic
  • under treatment of hormonal therapy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    resistive exercise

    resistive exercises using elastic band(Thera Band) Sets were at moderate intensity, 8-10 repetitions for every motion for 12 weeks

    Device: resistive exercise

  • Experimental
    Aerobic exercise

    Aerobic exercise in form of treadmill walking for 45 minutes for 12 weeks

    Device: aerobic exercise in form of treadmill walking

Interventions

  • Deviceresistive exercise

    resistive exercise by elastic band for 12 weeks

  • Deviceaerobic exercise in form of treadmill walking

    aerobic exercise in form of treadmill walking for 12 weeks

06

What researchers measure

Primary outcomes

  1. Assessment of changes in the systolic blood pressure

    using the mercury column sphygmomanometer

    Time frame: 12 weeks

Secondary outcomes

  1. Assessment of changes in the diastolic blood pressure

    using the mercury column sphygmomanometer

    Time frame: 12 weeks

07

Study locations

1 site
  • Al Azhar University
    Cairo, 11599, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — a randomized controlled trial to determine and compare effect of 12 weeks of resistive exercises versus aerobic exercises in treatment of postmenopausal hypertension

Supporting information: Sap, Icf, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03637985
Lead sponsor
Cairo University
Responsible party
Ghada Ebrahim El Refaye (Assistant Professor of physical therapy for women's health, Cairo University) — Principal investigator
First posted
Aug 20, 2018
Start date
Sep 1, 2017
Primary completion
Jul 30, 2018
Completion
Aug 1, 2018
Last update
Aug 20, 2018

Study contacts

ghada E elrefaye, Professor
principal investigator · Assistant professor of physical therapy for women's health

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion